Abstract
This review focuses on the value of several groups of agents for the prevention and treatment of mucositis. The review refers to alimentary mucositis as a generalized term that includes oral mucositis and gastrointestinal mucositis. This paper is part of the systematic review made by the mucositis study group which operates in the Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). Several new guidelines are suggested in this review as an update to the primary systematic review that was published by the same group in 2004.
MeSH terms
-
Administration, Topical
-
Adult
-
Analgesics / therapeutic use
-
Anesthetics, Local / therapeutic use
-
Animals
-
Anti-Infective Agents / therapeutic use
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Antineoplastic Agents / adverse effects
-
Child
-
Clinical Trials as Topic
-
Curcumin / therapeutic use
-
Dietary Supplements / standards
-
Disease Models, Animal
-
Drug Evaluation
-
Evidence-Based Medicine
-
Gastrointestinal Diseases / etiology
-
Gastrointestinal Diseases / therapy*
-
Graft vs Host Disease / complications
-
Humans
-
Medical Oncology / methods
-
Mucositis / etiology
-
Mucositis / therapy*
-
Neoplasms* / complications
-
Neoplasms* / therapy
-
Practice Guidelines as Topic*
-
Primary Prevention / methods
-
Radiotherapy / adverse effects
-
Stomatitis / etiology
-
Stomatitis / therapy*
Substances
-
Analgesics
-
Anesthetics, Local
-
Anti-Infective Agents
-
Anti-Inflammatory Agents, Non-Steroidal
-
Antineoplastic Agents
-
Curcumin